References
- Felson DT. Epidemiology of hip and knee osteoarthritis. Epidemiol Rev. 1988;10:1–28. doi:10.1093/oxfordjournals.epirev.a036019.
- Wuelling M, Vortkamp A. Chondrocyte proliferation and differentiation. Endocr Dev Karger Publishers. 2011;21:1–11. doi:10.1159/000328081.
- Messner K, Gillquist J. Cartilage repair: a critical review. Acta Orthop Scand. 1996;67(5):523–529. doi:10.3109/17453679608996682.
- Wojdasiewicz P, Poniatowski ŁA, Szukiewicz D. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm. 2014;2014:561459. doi:10.1155/2014/561459
- Chen S, Zhang L, Xu R, et al. TheBDKRB2+ 9/-9 Polymorphisms influence pro-inflammatory cytokine levels in knee osteoarthritis by altering TLR-2 Expression: clinical and in vitro Studies. Cell Physiol Biochem. 2016;38(3):1245–1256. doi:10.1159/000443072
- Zhang G, Sun Y, Wang Y, et al. MiR-502-5p inhibits IL-1β-induced chondrocyte injury by targeting TRAF2. Cell Immunol. 2016;302:50–57. doi:10.1016/j.cellimm.2016.01.007
- Larsson S, Englund M, Struglics A, et al. Interleukin-6 and tumor necrosis factor alpha in synovial fluid are associated with progression of radiographic knee osteoarthritis in subjects with previous meniscectomy. Osteoarthritis Cartilage. 2015;23(11):1906–1914. doi:10.1016/j.joca.2015.05.035
- Rowan AD, Litherland GJ, Hui W, et al. Metalloproteases as potential therapeutic targets in arthritis treatment. Expert Opin Ther Targets. 2008;12(1):1–18. doi:10.1517/14728222.12.1.1
- Dean DD, Martel-Pelletier J, Pelletier JP, et al. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest. 1989;84(2):678–685. doi:10.1172/JCI114215
- Mengshol JA, Vincenti MP, Coon CI, et al. Interleukin‐1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c‐Jun N‐terminal kinase, and nuclear factor κB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum. 2000;43(4):801–811. doi:10.1002/1529-0131(200004)43:4<801::aid-anr10>3.0.CO;2-4
- Vincenti MP, Brinckerhoff CE. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res. 2002;4(3):157–164. doi:10.1186/ar401
- Liacini A, Sylvester J, Li WQ, et al. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-κB) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol. 2002;21(3):251–262. doi:10.1016/s0945-053x(02)00007-0
- Zheng X, Xia C, Chen Z, et al. Requirement of the phosphatidylinositol 3-kinase/Akt signaling pathway for the effect of nicotine on interleukin-1beta-induced chondrocyte apoptosis in a rat model of osteoarthritis. Biochem Biophys Res Commun. 2012;423(3):606–612. doi:10.1016/j.bbrc.2012.06.045
- Loeser RF, Erickson EA, Long DL. Mitogen-activated protein kinases as therapeutic targets in osteoarthritis. Curr Opin Rheumatol. 2008;20(5):581–586. doi:10.1097/BOR.0b013e3283090463
- Xie L, Xie H, Chen C, et al. Inhibiting the PI3K/AKT/NF-κB signal pathway with nobiletin for attenuating the development of osteoarthritis: in vitro and in vivo studies. Food Funct. 2019;10(4):2161–2175. doi:10.1039/c8fo01786g
- Marcu KB, Otero M, Olivotto E, et al. NF-κB signaling: multiple angles to target OA. Curr Drug Targets. 2010;11(5):599–613. doi:10.2174/138945010791011938
- Fajardo M, Di Cesare PE. Disease-modifying therapies for osteoarthritis. Drugs Aging. 2005;22(2):141–161. doi:10.2165/00002512-200522020-00005
- Singh R, Akhtar N, Haqqi TM. Green tea polyphenol epigallocatechi3-gallate: inflammation and arthritis. Life Sci. 2010;86(25–26):907–918. doi:10.1016/j.lfs.2010.04.013
- Ishihara K, Nakayama K, Akieda S, et al. Simultaneous regeneration of full-thickness cartilage and subchondral bone defects in vivo using a three-dimensional scaffold-free autologous construct derived from high-density bone marrow-derived mesenchymal stem cells. Tissue Eng. 2014;9:98. doi:10.1186/s13018-014-0098-z
- Brittberg M, Lindahl A, Nilsson A, et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. Tissue Eng. 1994;331(14):889–895. doi:10.1056/NEJM199410063311401
- Mandl EW, Van Der Veen SW, Verhaar JA, et al. Serum-free medium supplemented with high-concentration FGF2 for cell expansion culture of human ear chondrocytes promotes redifferentiation capacity. Tissue Eng. 2002;8(4):573–580. doi:10.1089/107632702760240490
- McCarthy TL, Centrella M. Local IGF-I expression and bone formation. Growth Horm IGF Res. 2001;11(4):213–219. doi:10.1054/ghir.2001.0236
- Morales TI, Hascall VC. Factors involved in the regulation of proteoglycan metabolism in articular cartilage. Arthritis Rheum. 1989;32(10):1197–1201. doi:10.1002/anr.1780321003
- Middleton J, Tyler JA. Upregulation of insulin-like growth factor I gene expression in the lesions of osteoarthritic human articular cartilage. Ann Rheum Dis. 1992;51(4):440–447. doi:10.1136/ard.51.4.440
- Verschure PJ, Van Noorden CJ, Marle JV, et al. Articular cartilage destruction in experimental inflammatory arthritis: insulin-like growth factor-1 regulation of proteoglycan metabolism in chrondrocytes. Histochem J. 1996;28(12):835–857. doi:10.1007/BF02331388
- Fernandes JC, Martel‐Pelletier J, Pelletier JP. The role of cytokines in osteoarthritis pathophysiology. Biorheology. 2002;39(1,2):237–246.
- Shakibaei M, Seifarth C, John J, et al. Igf-I extends the chondrogenic potential of human articular chondrocytes in vitro: molecular association between Sox9 and Erk1/2. Biochem Pharmacol. 2006;2(11):1382–1395. doi:10.1016/j.bcp.2006.08.022
- Hickey DG, Frenkel SR, Di PC. Clinical applications of growth factors for articular cartilage repair. Am J Orthop. 2003;32(2):70–76.
- Oh CD, Chun JS. Signaling mechanisms leading to the regulation of differentiation and apoptosis of articular chondrocytes by insulin-like growth factor-1. J Biol Chem. 2003;278(38):36563–36571. doi:10.1074/jbc.M304857200
- D’Lima DD, Hashimoto S, Chen PC, et al. Prevention of chondrocyte apoptosis. J Bone Joint Surg Am. 2001;83:S25–26. doi:10.2106/00004623-200100021-00006
- Lo MY, Kim HT. Chondrocyte apoptosis induced by collagen degradation: inhibition by caspase inhibitors and IGF-1. J Orthop Res. 2004;22(1):140–144. doi:10.1016/S0736-0266(03)00117-7
- Pelletier JP, Fernandes JC, Brunet J, et al. In vivo selective inhibition of mitogen‐activated protein kinase kinase 1/2 in rabbit experimental osteoarthritis is associated with a reduction in the development of structural changes. Arthritis Rheum. 2003;48(6):1582–1593. doi:10.1002/art.11014
- Mankin HJ, Dorfman H, Lippiello L, et al. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips: II. correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am. 1971;53(3):523–537. doi:10.2106/00004623-197153030-00009
- Fortier L, Mohammed HO, Lust G, et al. Insulin-like growth factor-I enhances cell-based repair of articular cartilage. J Bone Joint Surg Br. 2002;84(2):276–288. doi:10.1302/0301-620x.84b2.11167
- Montaseri A, Busch F, Mobasheri A, et al. IGF-1 and PDGF-bb suppress IL-1β-induced cartilage degradation through down-regulation of NF-κB signaling: involvement of Src/PI-3K/AKT pathway. PLoS One. 2011;6(12):e28663. doi:10.1371/journal.pone.0028663.
- Roughley PJ. The structure and function of cartilage proteoglycans. Eur Cell Mater. 2006;12:92–101. doi:10.22203/ecm.v012a11
- Stetler-Stevenson WG, Yu AE. Proteases in invasion: matrix metalloproteinases. Seminr Cancer Biol. 2001;11(2):143–152. doi:10.1006/scbi.2000.0365
- Mitchell PG, Magna HA, Reeves LM, et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest. 1996;97(3):761–768. doi:10.1172/JCI118475
- Hernandez-Barrantes S, Bernardo M, Toth M, et al. Regulation of membrane type-matrix metalloproteinases. Semin Cancer Biol. 2002;12(2):131–138. doi:10.1006/scbi.2001.0421
- Hulboy DL, Rudolph LA, Matrisian LM. Matrix metalloproteinases as mediators of reproductive function. Mol Hum Reprod. 1997;3(1):27–45. doi:10.1093/molehr/3.1.27
- Lu S, Xiao X, Cheng M. Matrine inhibits IL-1β-induced expression of matrix metalloproteinases by suppressing the activation of MAPK and NF-κB in human chondrocytes in vitro. Int J Clin Exp Pathol. 2015;8(5):4764–4772.
- Rouse J, Cohen P, Trigon S, et al. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell. 1994;78(6):1027–1037. doi:10.1016/0092-8674(94)90277-1
- Bhowmick NA, Zent R, Ghiassi M, et al. Integrin β1 signaling is necessary for transforming growth factor-β activation of p38MAPK and epithelial plasticity. J Biol Chem. 2001;276(50):46707–46713. doi:10.1074/jbc.M106176200
- Yosimichi G, Nakanishi T, Nishida T, et al. CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen‐activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular‐signal regulated kinase (ERK). Eur J Biochem. 2001;268(23):6058–6065. doi:10.1046/j.0014-2956.2001.02553.x
- Boileau C, Martel-Pelletier J, Brunet J, et al. PD-0200347, an α2δ ligand of the voltage gated calcium channel, inhibits in vivo activation of the Erk1/2 pathway in osteoarthritic chondrocytes: a PKCα dependent effect. Ann Rheum Dis. 2006;65(5):573–580. doi:10.1136/ard.2005.041855
- Mendoza-Milla C, Rodríguez CM, Alarcón EC, et al. NF-κB activation but not PI3K/Akt is required for dexamethasone dependent protection against TNF-α cytotoxicity in L929 cells. FEBS Lett. 2005;579(18):3947–3952. doi:10.1016/j.febslet.2005.05.081
- Henrotin YE, Bruckner P, Pujol JP. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthr Cartil. 2003;11(10):747–755. doi:10.1016/s1063-4584(03)00150-x
- Lee HG, Yang JH. PCB126 induces apoptosis of chondrocytes via ROS-dependent pathways. Osteoarthritis Cartilage. 2012;20(10):1179–1185. doi:10.1016/j.joca.2012.06.004
- Jallali N, Ridha H, Thrasivoulou C, et al. Modulation of intracellular reactive oxygen species level in chondrocytes by IGF-1, FGF, and TGF-β1. Connect Tissue Res. 2007;48(3):149–158. doi:10.1080/03008200701331516